Avantor, Inc. (NYSE:AVTR – Free Report) – Investment analysts at Zacks Research dropped their Q3 2026 EPS estimates for Avantor in a report released on Tuesday, March 25th. Zacks Research analyst D. Dey now expects that the company will earn $0.27 per share for the quarter, down from their prior estimate of $0.29. The consensus estimate for Avantor’s current full-year earnings is $1.06 per share. Zacks Research also issued estimates for Avantor’s FY2026 earnings at $1.13 EPS and FY2027 earnings at $1.33 EPS.
Avantor (NYSE:AVTR – Get Free Report) last released its quarterly earnings data on Wednesday, February 12th. The company reported $0.27 EPS for the quarter, beating the consensus estimate of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same quarter in the prior year, the firm posted $0.22 earnings per share.
Get Our Latest Stock Analysis on AVTR
Avantor Price Performance
Shares of Avantor stock opened at $16.28 on Thursday. The firm has a market cap of $11.08 billion, a PE ratio of 15.65, a PEG ratio of 1.55 and a beta of 1.30. The stock has a 50 day moving average of $18.65 and a 200 day moving average of $21.53. The company has a current ratio of 1.07, a quick ratio of 0.70 and a debt-to-equity ratio of 0.54. Avantor has a 12 month low of $15.37 and a 12 month high of $28.00.
Institutional Trading of Avantor
A number of large investors have recently modified their holdings of AVTR. Dodge & Cox increased its holdings in Avantor by 44.9% during the 4th quarter. Dodge & Cox now owns 99,145,770 shares of the company’s stock worth $2,089,001,000 after purchasing an additional 30,727,673 shares during the period. Vanguard Group Inc. increased its stake in shares of Avantor by 1.9% during the fourth quarter. Vanguard Group Inc. now owns 63,969,754 shares of the company’s stock valued at $1,347,843,000 after buying an additional 1,211,418 shares during the period. Barrow Hanley Mewhinney & Strauss LLC raised its holdings in shares of Avantor by 41.4% in the fourth quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 30,528,092 shares of the company’s stock valued at $643,227,000 after acquiring an additional 8,936,879 shares in the last quarter. State Street Corp lifted its stake in Avantor by 58.0% in the third quarter. State Street Corp now owns 22,368,244 shares of the company’s stock worth $578,666,000 after acquiring an additional 8,206,695 shares during the period. Finally, Canada Pension Plan Investment Board lifted its stake in Avantor by 0.5% in the fourth quarter. Canada Pension Plan Investment Board now owns 21,037,089 shares of the company’s stock worth $443,251,000 after acquiring an additional 112,644 shares during the period. Hedge funds and other institutional investors own 95.08% of the company’s stock.
Insider Activity
In other Avantor news, EVP James Bramwell sold 3,758 shares of the business’s stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total value of $65,877.74. Following the completion of the sale, the executive vice president now directly owns 87,379 shares of the company’s stock, valued at $1,531,753.87. The trade was a 4.12 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Steven W. Eck sold 4,907 shares of the company’s stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $86,019.71. Following the completion of the transaction, the chief accounting officer now owns 40,604 shares in the company, valued at $711,788.12. This represents a 10.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.50% of the company’s stock.
Avantor Company Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Featured Stories
- Five stocks we like better than Avantor
- Election Stocks: How Elections Affect the Stock Market
- Energy Transfer: Powering Data With Dividends and Diversification
- What is the S&P/TSX Index?
- Qualcomm Stock Is Coiling for a Breakout
- Using the MarketBeat Stock Split Calculator
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.